Attached files
file | filename |
---|---|
10-Q - INVERNESS MEDICAL INNOVATIONS, INC. - ALERE INC. | b77452e10vq.htm |
EX-31.1 - EX-31.1 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ALERE INC. | b77452exv31w1.htm |
EX-31.2 - EX-31.2 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER - ALERE INC. | b77452exv31w2.htm |
EX-4.4 - EX-4.4 SECOND SUPPLEMENTAL INDENTURE DATED AS OF SEPTEMBER 22, 2009 - ALERE INC. | b77452exv4w4.htm |
Exhibit 32.1
Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
18 U.S.C. Section 1350,
as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
Each of the undersigned officers of Inverness Medical Innovations, Inc. (the Company) hereby
certifies, to his knowledge, that the Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended September 30, 2009 (the Report), as filed with the Securities and Exchange
Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d), as
applicable, of the Securities Exchange Act of 1934, as amended (the Exchange Act), and that the
information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company. This certification is being furnished as an
exhibit to the Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, and shall not be deemed filed for purposes of Section 18 of the
Exchange Act, or otherwise subject to the liability of that section. This certification will not be
deemed to be incorporated by reference into any filing under the Securities Act of 1933, as
amended, or the Exchange Act, regardless of any general incorporation language in such filing,
except to the extent that the Company specifically incorporates this certification by reference.
Date: November 9, 2009 | /s/ Ron Zwanziger | |||
Ron Zwanziger | ||||
Chief Executive Officer | ||||
Date: November 9, 2009 | /s/ David Teitel | |||
David Teitel | ||||
Chief Financial Officer | ||||
A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form
within the electronic version of this written statement required by Section 906, has been provided
to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.